142 related articles for article (PubMed ID: 35871389)
1. Thromboprophylaxis for inpatient with advanced cancer receiving palliative care: A retrospective study.
Al-Ansari AM; Abd-El-Gawad WM; AboSerea SM; Ali AA; Abdullah MM; Ali FAS; ElShereafy EES; Bahnasy MAEB
Eur J Haematol; 2022 Nov; 109(5):494-503. PubMed ID: 35871389
[TBL] [Abstract][Full Text] [Related]
2. Thromboprophylaxis for inpatients with advanced cancer in palliative care settings: A systematic review and narrative synthesis.
Cai R; Zimmermann C; Krzyzanowska M; Granton J; Hannon B
Palliat Med; 2019 May; 33(5):486-499. PubMed ID: 30819046
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for inpatient venous thromboembolism despite thromboprophylaxis.
Wang TF; Wong CA; Milligan PE; Thoelke MS; Woeltje KF; Gage BF
Thromb Res; 2014 Jan; 133(1):25-9. PubMed ID: 24300584
[TBL] [Abstract][Full Text] [Related]
4. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
[TBL] [Abstract][Full Text] [Related]
5. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
[TBL] [Abstract][Full Text] [Related]
6. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis.
Zhang C; Zhang Z; Mi J; Wang X; Zou Y; Chen X; Nie Z; Luo X; Gan R
Medicine (Baltimore); 2019 Jun; 98(23):e15833. PubMed ID: 31169685
[TBL] [Abstract][Full Text] [Related]
7. Considerations for pharmacologic thromboprophylaxis following inpatient brachytherapy for gynecologic malignancies.
McAlarnen LA; Small C; Tostrud L; Pan AY; Erickson B; Bedi M; Bradley WH
Brachytherapy; 2023; 22(5):630-639. PubMed ID: 37394350
[TBL] [Abstract][Full Text] [Related]
8. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Di Nisio M; Porreca E; Otten HM; Rutjes AW
Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
[TBL] [Abstract][Full Text] [Related]
9. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
[TBL] [Abstract][Full Text] [Related]
10. Primary Thromboprophylaxis in Individuals without Cancer Admitted to a Geriatric Palliative Care Unit.
Gurau AJ; Berall A; Karuza J; Perri GA
J Am Geriatr Soc; 2018 Feb; 66(2):346-349. PubMed ID: 29144543
[TBL] [Abstract][Full Text] [Related]
11. Thromboprophylaxis in cancer patients in hospice.
Zabrocka E; Wojtukiewicz MZ; Sierko E
Adv Clin Exp Med; 2018 Feb; 27(2):283-289. PubMed ID: 29521074
[TBL] [Abstract][Full Text] [Related]
12. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
[TBL] [Abstract][Full Text] [Related]
13. HIDDEN2: Study protocol for the hospital deep vein thrombosis detection study in patients with cancer receiving palliative care.
Kitson T; Osborne E; Noble S; Pease N; Alikhan R; Bryant C; Groves T; Wallace R; Walker S; Seddon K; Smith D; Raisanen L; Smith J; Thomas I; Upton L; Casbard A
BMJ Open; 2023 Sep; 13(9):e073049. PubMed ID: 37669841
[TBL] [Abstract][Full Text] [Related]
14. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.
Fontana P; Casini A; Robert-Ebadi H; Glauser F; Righini M; Blondon M
Swiss Med Wkly; 2020 Jun; 150():w20301. PubMed ID: 32640479
[TBL] [Abstract][Full Text] [Related]
16. The risk of venous thromboembolism in surgically treated hip fracture: A retrospective cohort study of 5184 patients.
Beauchamp-Chalifour P; Belzile ÉL; Michael R; Langevin V; Gaudreau N; Normandeau N; Bédard L; Pelet S
Orthop Traumatol Surg Res; 2022 Feb; 108(1):103142. PubMed ID: 34775033
[TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
Dwyer JP; Javed A; Hair CS; Moore GT
Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
[TBL] [Abstract][Full Text] [Related]
18. Inpatient prophylaxis in cancer patients: where is the evidence?
Patell R; Zwicker JI
Thromb Res; 2020 Jul; 191 Suppl 1():S85-S90. PubMed ID: 32736785
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a thromboprophylaxis quality improvement project in a palliative care unit.
Legault S; Tierney S; Sénécal I; Pereira J
J Pain Symptom Manage; 2011 Mar; 41(3):503-10. PubMed ID: 21145701
[TBL] [Abstract][Full Text] [Related]
20. Right needle, right patient, right time? A national flash-mob audit of thromboprophylaxis in palliative care.
Crabtree A; Kavanagh E; Chamberlain C; Wakefield D; Daniel R; Schofield G; Star A; Yardley S; Whyte I; Chu C; Billett H; Noble S;
Thromb Res; 2023 Mar; 223():95-101. PubMed ID: 36738665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
